International Conference on Biomedical Engineering
We will travel to Barcelona from August 19-21 to take part in the 11th International Conference on Biomedical Engineering and Systems (which will also be held virtually). This meeting is a unique opportunity to link up with researchers from all over the world.
The 11th International Conference on Biomedical Engineering and Systems (ICBES 2024) is aiming to become the leading annual conference in the fields related to biomedical engineering and systems.
- The aim of this biomedical engineering conference is to bring together academics from around the world to showcase advances in related fields and foster an environment conducive to sharing ideas and information.
TECNALIA's contribution
TECNALIA employees Verónica Mora and Marina Peña, who are health researchers and experts on Biomaterials, will have several slots and give a number of lectures at this international meeting.
- Verónica Mora will contribute to the congress programme with several slots:
- A talk as part of the DeDNAed project, which combines physics and biology to develop new biosensors.
- “Enzyme activity monitoring in industrial solid-state fermentation processes based on colorimetric LoC compatible with R2R fabrication”. A talk on the European NGM “NextGenMicrofluidics” project (Next Generation Testbed for scaling up microfluidic devices based on nanometric surfaces and membranes) in which TECNALIA has been involved and which proposes reaching an unparalleled level in the production capacity of flexible lab-on-a-chipsystems, the so-called labs-on-a-foil
- "Microfluidic chip for in vitro neuronal cell culture under electrical stimulation”. (Demo in relation to the NGM (NextGenMicrofluidics) project.
- Marina Peña will present some of the advances related to the ONBODY project (Elkartek KK-2023/00070), on which the health team is working: it is based on research into new biomedical sensor systems for digital health.
- She will explain the proof-of-concept development of an ingestible pill demonstrator for the real-time and in situ monitoring of digestive tract biomarkers that predict the onset of or diagnose inflammatory bowel diseases.